People and Business News – 4/23
The latest people and business news from the past month, all in one place.
People News
MMS Holdings announced the addition of Dr. Philip Breitfeld and Dr. Bernhardt Zeiher to its board of scientific advisors. Dr. Breitfeld is currently the chief medical officer for Allterum Therapeutics. Dr. Zeiher has also been the chief medical officer for Astellas Pharma for the past 12 years.
Catawba Research announced the hiring of Andy Silverman, PhD, as chief operating officer. Previously, Silverman worked as EVP, Global Operations for Syneos Health.
Greenphire announced the appointment of Steve Geffon to be its new chief commercial officer. Prior to joining Greenphire, Geffon spent three years in the same role at Science 37.
CluePoints revealed the hiring of Amit Patel as its new CFO. Patel joins CluePoints after serving in the same role at Siteimprove.
Innovative Trials appointed Eloise Moffett as its first commercial vice president. Before joining Innovative Trials, Moffet spent over two years as the senior director of business development for mdgroup.
EmVenio Research announced the appointment of Mark Mackenzie, MD, as chief medical officer. Previously, Mackenzie served as the vice president of clinical affairs at M-3 Wake Research.
COTA Inc. announced the hiring of Sandy Leonard as its chief commercial officer. Concurrently, Leonard is the founder of DAISE Consulting LLC.
TOTAL Diversity Clinical Management introduced three new executives to its staff including Gabrielle DeBoer as VP, business development; Jeremy Mitchell as director, business development; and Crystal Thigpen as marketing and communications director.
Recognition
Cluepoints has been shortlisted for the 2023 Citeline Awards in the Best Use of Artificial Intelligence in Clinical Trials category.
Final ENLIVEN Trial Results Confirm Long-Term Benefit of Turalio in Tenosynovial Giant Cell Tumor
July 9th 2025In final data from the Phase III ENLIVEN study, Turalio (pexidartinib) demonstrated durable tumor responses and a consistent safety profile in patients with symptomatic TGCT not amenable to surgery.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Expands Farapulse PFA Approval to Persistent AF After Strong ADVANTAGE AF Trial Results
July 7th 2025Boston Scientific’s Farapulse Pulsed Field Ablation System is now approved for treating persistent atrial fibrillation, following 12-month data from the ADVANTAGE AF trial showing strong safety, high freedom from AF, and no major complications.
Effect of AI/ML, Real World Evidence and Master Protocols on Trial Success
July 7th 2025How the application of artificial intelligence, broader use of real-world evidence, decentralized clinical trials, master protocols, and risk-based quality monitoring, together with strong ethical oversight and increased collaboration, are contributing to better healthcare delivery and strengthening the role of clinical research in driving global health progress.
